Life sciences tools company Agilent Technologies (NYSE:A) in Q4 CY2024, with sales up 1.4% year on year to $1.68 billion. On the other hand, next quarter’s revenue guidance of $1.63 billion was ...

Valued at a market cap of $34.5 billion, Agilent Technologies, Inc. (A) is an original equipment manufacturer of a ...

Life sciences tools company Agilent Technologies (NYSE:A) will be announcing earnings results tomorrow after market close. Here’s what you need to know. Agilent beat analysts’ revenue ...

Agilent Technologies is a global leader in life sciences, diagnostics and applied markets, recognized for uncompromising integrity in all they do. Their mission is to advance quality of life by ...

These changes have no impact on Agilent’s consolidated financial statements. Life Sciences and Diagnostics Markets Group Agilent’s Life Sciences and Diagnostics Markets Group (LDG) reported ...

In November, the company said that it would restructure its business into three segments — the life sciences and diagnostics markets group, applied markets group and Agilent CrossLab group with ...

The stock's fall snapped a two-day winning streak.

What Happened: In a recent Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday, Podolsky increased their investment in Agilent Technologies by purchasing 1,819 shares through ...

With a strong presence in life sciences and diagnostics, Agilent supports drug discovery, genetic research, and precision medicine through cutting-edge diagnostic tools. However, in the longer ...

This was the stock's second consecutive day of losses.